Fidelity Investments’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-200
| Closed | -$346 | – | 5705 |
|
2023
Q1 | $346 | Buy |
+200
| New | +$346 | ﹤0.01% | 4824 |
|
2022
Q4 | – | Sell |
-8
| Closed | – | – | 5713 |
|
2022
Q3 | $0 | Sell |
8
-53,730
| -100% | – | ﹤0.01% | 5657 |
|
2022
Q2 | $245K | Hold |
53,738
| – | – | ﹤0.01% | 3076 |
|
2022
Q1 | $564K | Hold |
53,738
| – | – | ﹤0.01% | 2947 |
|
2021
Q4 | $805K | Hold |
53,738
| – | – | ﹤0.01% | 2712 |
|
2021
Q3 | $1.6M | Hold |
53,738
| – | – | ﹤0.01% | 2618 |
|
2021
Q2 | $1.81M | Hold |
53,738
| – | – | ﹤0.01% | 2567 |
|
2021
Q1 | $2.23M | Sell |
53,738
-3,432
| -6% | -$142K | ﹤0.01% | 2450 |
|
2020
Q4 | $3.46M | Hold |
57,170
| – | – | ﹤0.01% | 2278 |
|
2020
Q3 | $7.62M | Hold |
57,170
| – | – | ﹤0.01% | 1921 |
|
2020
Q2 | $9.64M | Buy |
57,170
+32,756
| +134% | +$5.52M | ﹤0.01% | 1830 |
|
2020
Q1 | $3.51M | Sell |
24,414
-114
| -0.5% | -$16.4K | ﹤0.01% | 2041 |
|
2019
Q4 | $8.09M | Buy |
24,528
+4,689
| +24% | +$1.55M | ﹤0.01% | 1920 |
|
2019
Q3 | $9.92M | Buy |
19,839
+5,811
| +41% | +$2.91M | ﹤0.01% | 1830 |
|
2019
Q2 | $8.52M | Buy |
14,028
+982
| +8% | +$597K | ﹤0.01% | 1941 |
|
2019
Q1 | $7.96M | Buy |
13,046
+5,675
| +77% | +$3.46M | ﹤0.01% | 1941 |
|
2018
Q4 | $2.69M | Buy |
7,371
+6,171
| +514% | +$2.25M | ﹤0.01% | 2212 |
|
2018
Q3 | $810K | Buy |
+1,200
| New | +$810K | ﹤0.01% | 2496 |
|